Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients

被引:19
|
作者
Clarke, Christina L. [1 ]
Kushi, Lawrence H. [2 ]
Chubak, Jessica [3 ]
Pawloski, Pamala A. [4 ]
Bulkley, Joanna E. [5 ]
Epstein, Mara M. [6 ,7 ]
Burnett-Hartman, Andrea N. [1 ]
Powell, Bethan [8 ]
Pearce, Celeste L. [9 ]
Feigelson, Heather Spencer [1 ]
机构
[1] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA
[2] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
[3] Kaiser Permanente Washington, Hlth Res Inst, Seattle, WA USA
[4] HealthPartners Inst, Bloomington, MN USA
[5] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA
[6] Meyers Primary Care Inst, Worcester, MA USA
[7] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA
[8] Kaiser Permanente Northern Calif, Gynecol Oncol Program, San Francisco, CA USA
[9] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA
关键词
D O I
10.1158/1055-9965.EPI-18-1324
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Relatively little is known about factors associated with long-term survival (LTS) following a diagnosis of ovarian cancer. Methods: We conducted a retrospective study of high-grade serous ovarian cancer (HGSOC) to explore predictors of LTS (defined as >= 7 years of survival) using electronic medical record data from a network of integrated health care systems. Multivariable logistic regression with forward selection was used to compare characteristics of women who survived >= 7 years after diagnosis (n = 148) to those who died within 7 years of diagnosis (n = 494). Results: Our final model included study site, age, stage at diagnosis, CA-125, comorbidity score, receipt of chemotherapy, BMI, and four separate comorbid conditions: weight loss, depression, hypothyroidism, and liver disease. Of these, only younger age, lower stage, and depression were statistically significantly associated with LTS. Conclusions: We did not identify any new characteristics associated with HGSOC survival. Impact: Prognosis of ovarian cancer generally remains poor. Large, pooled studies of ovarian cancer are needed to identify characteristics that may improve survival.
引用
收藏
页码:996 / 999
页数:4
相关论文
共 50 条
  • [21] Overexpression of stromal biglycan correlates with improved survival in patients with high-grade serous ovarian cancer
    Carroll, A.
    Thompson, M. S.
    Co, C.
    Zaid, T. M.
    Wong, K. K.
    Yeung, T. L.
    Schmandt, R.
    Birrer, M. J.
    Mok, S. C.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 438 - 438
  • [22] Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival
    Darb-Esfahani, Silvia
    Kolaschinski, Ivonne
    Trillsch, Fabian
    Mahner, Sven
    Concin, Nicole
    Vergote, Ignace
    Van Nieuwenhuysen, Els
    Achimas-Cadariu, Patriciu
    Glajzer, Joanna
    Woopen, Hannah
    Wienert, Stefan
    Taube, Eliane T.
    Stanske, Mandy
    Kulbe, Hagen
    Denkert, Carsten
    Sehouli, Jalid
    Braicu, Elena I.
    HISTOPATHOLOGY, 2018, 73 (06) : 1002 - 1012
  • [23] Immune cell landscapes are associated with high-grade serous ovarian cancer survival
    Zhang, Guoan
    Zhang, Yan
    Zhang, Jingjing
    Yang, Xiaohui
    Sun, Wenjie
    Liu, Ying
    Liu, Yingfu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival
    Zwimpfer, T. A.
    Pandey, A.
    Fereday, S.
    Coelho, R. J. B-N.
    Twomey, L.
    Ariyaratne, D.
    Traficante, N.
    Jacob, F.
    Eller, R.
    Heinzelmann-Schwarz, V.
    Christie, E. L.
    Kennedy, C.
    Au-Yeung, G.
    Ramus, S.
    Koebel, M.
    Nelson, B.
    Goode, E. L.
    DeFazio, A.
    Bowtell, D. D. L.
    Garsed, D. W.
    ANNALS OF ONCOLOGY, 2024, 35 : S571 - S571
  • [25] Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma
    Stur, Elaine
    Bayraktar, Emine
    Dal Molin, Graziela Zibetti
    Wu, Sherry Y.
    Mangala, Lingegowda S.
    Yao, Hui
    Wang, Ying
    Ram, Prahlad T.
    Corvigno, Sara
    Chen, Hu
    Liang, Han
    Tworoger, Shelley S.
    Levine, Douglas A.
    Lutgendorf, Susan K.
    Liu, Jinsong
    Moore, Kathleen N.
    Baggerly, Keith A.
    Karlan, Beth Y.
    Sood, Anil K.
    CANCERS, 2022, 14 (17)
  • [26] The Changing View of High-Grade Serous Ovarian Cancer
    Berns, Els M. J. J.
    Bowtell, David D.
    CANCER RESEARCH, 2012, 72 (11) : 2701 - 2704
  • [27] The genesis and evolution of high-grade serous ovarian cancer
    Bowtell, David D. L.
    NATURE REVIEWS CANCER, 2010, 10 (11) : 803 - 808
  • [28] The genesis and evolution of high-grade serous ovarian cancer
    David D. L. Bowtell
    Nature Reviews Cancer, 2010, 10 : 803 - 808
  • [29] Cell Origins of High-Grade Serous Ovarian Cancer
    Kim, Jaeyeon
    Park, Eun Young
    Kim, Olga
    Schilder, Jeanne M.
    Coffey, Donna M.
    Cho, Chi-Heum
    Bast, Robert C., Jr.
    CANCERS, 2018, 10 (11)
  • [30] Proteogenomic characterization of high-grade serous ovarian cancer
    McDermott, Jason E.
    Payne, Samuel
    Ray, Debjit
    Petyuk, Vladislav
    Moore, Ronald
    Gritsenko, Marina
    Smith, Richard
    Rodland, Karin
    CANCER RESEARCH, 2016, 76